Trial Profile
Clinical Study Using Antiaging Glycopeptide (PKX-001) in Islet Transplantation
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Oct 2023
Price :
$35
*
At a glance
- Drugs PKX 001 (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; First in man
- 09 Oct 2023 Planned End Date changed from 1 Sep 2023 to 1 Sep 2024.
- 09 Oct 2023 Planned primary completion date changed from 1 Sep 2023 to 1 Sep 2024.
- 12 Oct 2022 Planned End Date changed from 1 Jan 2023 to 1 Sep 2023.